Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
118.25 USD   +0.15%
10/01Moderna refused China request to reveal vaccine technology - FT
RE
09/30Insider Sell: Moderna
MT
09/30Two thirds of U.S. adults don't plan on getting COVID boosters soon - poll
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Goldman Sachs Raises Moderna's Price Target to $296 From $290, Maintains Buy Rating

08/04/2022 | 11:19am EDT


© MT Newswires 2022
All news about MODERNA, INC.
10/01Moderna refused China request to reveal vaccine technology - FT
RE
09/30Insider Sell: Moderna
MT
09/30Two thirds of U.S. adults don't plan on getting COVID boosters soon - poll
RE
09/30Moderna Creates New Executive Committee Role Ahead of New Product Launches
AQ
09/30A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia
RE
09/29Around 3.2 million Americans received updated COVID boosters last week -CDC
RE
09/29U.S. CDC Says As Of Sept 28, 3.2 Mln People Received An Updated Booster Dose For Covid-..
RE
09/29Moderna, Inc. : Change in Directors or Principal Officers, Regulation FD Disclosure, Finan..
AQ
09/29Moderna, Inc. Announces Management Changes
CI
09/29Moderna Adds New Role Ahead of Product Launches
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 836 M - -
Net income 2022 10 884 M - -
Net cash 2022 16 503 M - -
P/E ratio 2022 4,52x
Yield 2022 -
Capitalization 46 259 M 46 259 M -
EV / Sales 2022 1,36x
EV / Sales 2023 2,58x
Nbr of Employees 2 700
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 118,25 $
Average target price 218,07 $
Spread / Average Target 84,4%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-53.44%46 259
LONZA GROUP AG-36.15%36 760
IQVIA HOLDINGS INC.-35.80%33 784
SEAGEN INC.-11.49%25 236
ALNYLAM PHARMACEUTICALS, INC.18.03%24 025
CELLTRION, INC.-11.36%16 839